Tacrolimus: Difference between revisions

(special populations edits)
(contraindications)
Line 37: Line 37:
==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
*hypersensitivity to castor oil derivatives (IV form)
*liver transplant use (ER cap form)
*electrolyte abnormalities, uncorrected
*congenital long QT syndrome
*caution if QT prolongation
*caution if QT prolongation family hx
*caution if torsades de pointes hx
*caution if ventricular arrhythmias
*caution if bradycardia
*caution if recent MI
*caution if CHF
*caution in female pts
*caution in black pts
*caution in Hispanic pts
*caution if renal impairment
*caution if hepatic impairment


==Adverse Reactions==
==Adverse Reactions==

Revision as of 03:26, 9 February 2016

Administration

  • Type: immunosuppressant
  • Dosage Forms: 0.5,1,5
  • Routes of Administration: PO, topical, IV
  • Common Trade Names:Prograf

Adult Dosing

Heart transplant rejection prophylaxis

  • 0.075 mg/kg/day PO divided q12h
  • Start: >6h post-transplant; Info: adjust dose based on serum levels

Liver transplant rejection prophylaxis

  • 0.1-0.15 mg/kg/day PO divided q12h
  • Start: >6h post-transplant; Info: adjust dose based on serum levels

Kidney transplant rejection prophylaxis

  • 0.1-0.2 mg/kg/day PO divided q12h
  • Start: w/in 24h post-transplant; delay if renal fxn not adequate; Info: adjust dose based on serum levels

Pediatric Dosing

Liver transplant rejection prophylaxis

  • 0.15-0.2 mg/kg/day PO divided q12h
  • Start: >6h post-transplant; Info: adjust dose based on serum levels

Special Populations

Renal Dosing

  • Adult:
    • kidney transplant: give lowest recommended dose, may consider further dose decr.; postop oliguria: start 6-24h post-transplant; may delay until renal fxn adequate; HD: not defined
    • all other transplants: give lowest recommended dose, may consider further dose decr.; HD: not defined
  • Pediatric: give lowest recommended dose, may consider further dose decr.; HD: not defined

Hepatic Dosing

  • Adult: give lowest recommended dose, may consider further dose decr.; Child-Pugh Score >10: decr. dose, amount not defined
  • Pediatric: give lowest recommended dose, may consider further dose decr.; Child-Pugh Score >10: decr. dose, amount not defined

Contraindications

  • Allergy to class/drug
  • hypersensitivity to castor oil derivatives (IV form)
  • liver transplant use (ER cap form)
  • electrolyte abnormalities, uncorrected
  • congenital long QT syndrome
  • caution if QT prolongation
  • caution if QT prolongation family hx
  • caution if torsades de pointes hx
  • caution if ventricular arrhythmias
  • caution if bradycardia
  • caution if recent MI
  • caution if CHF
  • caution in female pts
  • caution in black pts
  • caution in Hispanic pts
  • caution if renal impairment
  • caution if hepatic impairment

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References